Cussenot O - Search Results

1

[Role of endoscopy in the management of upper urinary tract tumors].

Roupret M, Cussenot O, Chartier-Kastler E, Thibault P, Richard F, Conort P, Traxer O. Roupret M, et al. Among authors: cussenot o. Prog Urol. 2006 Nov;16(5):537-41. Prog Urol. 2006. PMID: 17175946 Review. French.

2

[Cystectomy with preservation of the prostate in the treatment of bladder tumours: anatomical basis, surgical techniques, indications and results].

Sèbe P, Traxer O, Cussenot O, Haab F, Thibault P, Gattegno B. Sèbe P, et al. Among authors: cussenot o. Prog Urol. 2003 Dec;13(6):1279-85. Prog Urol. 2003. PMID: 15000299 Review. French.

3

[Genetic features of urothelial carcinoma of the bladder and the upper urinary tract].

Cussenot O, Davin JL. Cussenot O, et al. Prog Urol. 2003 Nov;13(5 Suppl 2):1233. Prog Urol. 2003. PMID: 15816391 French. No abstract available.

4

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.

Rouprêt M, Fromont G, Azzouzi AR, Catto JW, Vallancien G, Hamdy FC, Cussenot O. Rouprêt M, et al. Among authors: cussenot o. Urology. 2005 Jun;65(6):1233-7. doi: 10.1016/j.urology.2005.01.019. Urology. 2005. PMID: 15922421

5

[Transitional cell carcinoma of the upper urinary tract new concepts in management].

Rouprêt M, Cussenot O. Rouprêt M, et al. Among authors: cussenot o. Presse Med. 2005 Apr 23;34(8):601-7. doi: 10.1016/s0755-4982(05)83989-2. Presse Med. 2005. PMID: 15962502 Review. French.

6

Accuracy of the routine detection of mutation in mismatch repair genes in patients with susceptibility to hereditary upper urinary tract transitional cell carcinoma.

Rouprêt M, Coulet F, Azzouzi AR, Fromont G, Cussenot O. Rouprêt M, et al. Among authors: cussenot o. BJU Int. 2005 Jul;96(1):149-51. doi: 10.1111/j.1464-410X.2005.05585.x. BJU Int. 2005. PMID: 15963139

7

Microsatellite instability and transitional cell carcinoma of the upper urinary tract.

Rouprêt M, Azzouzi AR, Cussenot O. Rouprêt M, et al. Among authors: cussenot o. BJU Int. 2005 Sep;96(4):489-92. doi: 10.1111/j.1464-410X.2005.05671.x. BJU Int. 2005. PMID: 16104897 Review. No abstract available.

8

Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.

Fromont G, Rouprêt M, Amira N, Sibony M, Vallancien G, Validire P, Cussenot O. Fromont G, et al. Among authors: cussenot o. Eur Urol. 2005 Nov;48(5):764-70. doi: 10.1016/j.eururo.2005.07.005. Epub 2005 Aug 1. Eur Urol. 2005. PMID: 16126329

9

Outcome after radical prostatectomy in young men with or without a family history of prostate cancer.

Rouprêt M, Fromont G, Bitker MO, Gattegno B, Vallancien G, Cussenot O. Rouprêt M, et al. Among authors: cussenot o. Urology. 2006 May;67(5):1028-32. doi: 10.1016/j.urology.2005.11.035. Urology. 2006. PMID: 16698363

10

Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.

Rouprêt M, Hupertan V, Traxer O, Loison G, Chartier-Kastler E, Conort P, Bitker MO, Gattegno B, Richard F, Cussenot O. Rouprêt M, et al. Among authors: cussenot o. Urology. 2006 Jun;67(6):1181-7. doi: 10.1016/j.urology.2005.12.034. Urology. 2006. PMID: 16765178

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

519 results

Search Page

Filters